|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.255 USD | +4.40% |
|
+9.31% | +93.91% |
| Market Cap | 959M 845M 779M 729M 1.37B 90.44B 1.39B 9.36B 3.63B 44.61B 3.6B 3.52B 155B | P/E 2026 * |
-13.7x | P/E 2027 * | -11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 959M 845M 779M 729M 1.37B 90.44B 1.39B 9.36B 3.63B 44.61B 3.6B 3.52B 155B | EV / Sales 2026 * |
25.1x | EV / Sales 2027 * | 47.6x |
| Free-Float |
98.45% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lexicon Pharmaceuticals, Inc.
| 1 day | +4.40% | ||
| 1 week | +9.31% | ||
| Current month | +2.29% | ||
| 1 month | +8.25% | ||
| 3 months | +29.65% | ||
| 6 months | +81.30% | ||
| Current year | +93.91% |
| 1 week | 1.98 |  | 2.27 |
| 1 month | 1.8 | | 2.27 |
| Current year | 1.1 | | 2.53 |
| 1 year | 0.77 | | 2.53 |
| 3 years | 0.28 | | 3.73 |
| 5 years | 0.28 | | 6.33 |
| 10 years | 0.28 | | 19.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Exton
CEO | Chief Executive Officer | 56 | 2024-07-07 |
Scott Coiante
DFI | Director of Finance/CFO | 59 | 2025-01-01 |
Michael Davies
CTO | Chief Tech/Sci/R&D Officer | - | 2025-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Barker
CHM | Chairman | 83 | 2004-12-31 |
Ray Debbane
CHM | Chairman | 71 | 2012-02-26 |
| Director/Board Member | 67 | 2007-08-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-02 | Fiscal year | Director | 178,624 | 0.0402% | ||
| 06-02 | Fiscal year | Director | 178,624 | 0.0402% | ||
| 06-02 | The Invus Group LLC
| Other | Company | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.40% | +9.31% | +189.50% | +2.76% | 959M | |
| -7.92% | -4.05% | +53.28% | +109.11% | 57.55B | |
| +8.55% | +17.56% | +76.80% | +82.31% | 47.08B | |
| -0.19% | -1.80% | -13.83% | -15.31% | 22.92B | |
| +2.27% | +6.54% | -0.95% | +426.82% | 22.14B | |
| +4.17% | +8.06% | +32.41% | -14.07% | 16.33B | |
| -0.15% | +4.15% | +27.79% | -34.36% | 15.97B | |
| +2.83% | +0.67% | +15.46% | +171.27% | 12.9B | |
| +5.94% | +17.05% | +143.80% | +296.09% | 12.85B | |
| +1.14% | +3.73% | +81.94% | +120.42% | 11.84B | |
| Average | +2.09% | +7.34% | +60.62% | +114.51% | 22.05B | |
| Weighted average by Cap. | +0.84% | +8.49% | +47.68% | +117.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.17M 33.6M 30.99M 28.99M 54.31M 3.6B 55.33M 372M 144M 1.77B 143M 140M 6.17B | 20.15M 17.74M 16.37M 15.31M 28.68M 1.9B 29.21M 197M 76.18M 937M 75.67M 74.02M 3.26B |
| Net income | -66.94M -58.93M -54.36M -50.84M -95.25M -6.31B -97.03M -653M -253M -3.11B -251M -246M -10.83B | -88.26M -77.7M -71.67M -67.03M -126M -8.32B -128M -861M -334M -4.1B -331M -324M -14.28B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-24 | US$2.235 | +3.47% | 1,487,646 |
| 26-06-23 | US$2.160 | +0.47% | 2,774,239 |
| 26-06-22 | US$2.150 | +6.97% | 3,035,727 |
| 26-06-18 | US$2.010 | -1.47% | 3,927,187 |
| 26-06-17 | US$2.040 | +4.62% | 2,622,399 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXRX Stock
Select your edition
All financial news and data tailored to specific country editions
